Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
NewsBuilding a successful startup goes beyond developing a product or service—you must be sure you are diving into a profitable market, and your product can cater to consumers' needs.
StrategyAlibaba Group Holding Limited announced today it has signed a strategic agreement with Shanghai Media Group
FinanceFor millions of Australians, financial security seems further away than ever. As banks across the country post record profits, all whilst being seemingly unaware of the financial situations of everyday people, their attitudes remain poor and their lack of pers
FinanceFounded in 2007, BRT is a dynamic and unique firm that specialises in providing middle and back office support to asset managers, hedge funds, private banks and family offices.
FinanceMany retirees, and those on the cusp of retirement, should consider revising their personal financial strategy, warns the chief executive of one of the world’s largest independent financial advisory firms.
InnovationA helpful guide for those who want to start a virtual assistant business, including effective virtual assistant business tools to help your new business thrive.
Corporate Social ResponsibilityIn the demanding world of fleet management, ensuring the safety and well-being of drivers is paramount. Fatigue, an often-underestimated hazard, poses significant risks to the drivers, public safety, and the company's reputation.
InnovationKPMG's comment on news showing $1bn (£648m) has been stolen in cyber-attacks since 2013.
LegalMaclay Murray & Spens Advises Phoenix Fund Services During Maitland's Acquisition
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
